CD19 and agammaglobulinemia: Four percent (3/68) exhibited only immunological abnormalities in the absence of a clinical related phenotype: one patient had hypogammaglobulinemia and decreased CD19 + and CD4 + cells, second had decreased TH17 and third hypogammaglobulinemia and decreased CD19 + cells.